World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
33986
World Ranking
11669
National Ranking
5981

Research.com Recognitions

  • 2015 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Kathleen R. Cho is affiliated with the University of Michigan-Ann Arbor in the United States. Their research spans multiple aspects of medicine, with a focus on reproductive medicine, molecular biology, obstetrics and gynecology, cancer research, and immunology.

The primary subjects of their work include:

  • Ovarian cancer diagnosis and treatment
  • Endometrial and cervical cancer treatments
  • Cancer mechanisms and therapy
  • Reproductive system and pregnancy
  • Single-cell and spatial transcriptomics
  • Epigenetics and DNA methylation
  • Cancer, lipids, and metabolism

Among the recent papers authored or co-authored by Kathleen R. Cho are:

  • Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy, 2020, published in Journal of Clinical Investigation
  • Altering the Microbiome Inhibits Tumorigenesis in a Mouse Model of Oviductal High-Grade Serous Carcinoma, 2021, published in Cancer Research
  • Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer, 2022, published in Nature Metabolism
  • Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance, 2024, published in Cell
  • Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival, 2020, published in Gynecologic Oncology

The scientist frequently publishes in these venues:

  • Clinical Cancer Research
  • Cancer Research
  • Gynecologic Oncology
  • Journal of Clinical Investigation
  • Cancers

Frequent co-authors collaborating on their work include:

  • Yali Zhai
  • Eric R. Fearon
  • Celeste Leigh Pearce
  • Malcolm C. Pike
  • Alice W. Lee

Kathleen R. Cho has been recognized as a member of the National Academy of Medicine since 2015 and is also a member of the Association of American Physicians.

Best Publications

  • Identification of a chromosome 18q gene that is altered in colorectal cancers

    Eric R. Fearon;Kathleen R. Cho;Janice M. Nigro;Scott E. Kern

  • p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes

    Guido T. Bommer;Isabelle Gerin;Ying Feng;Andrew J. Kaczorowski

  • Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.

    Dongjun Peng;Ilona Kryczek;Nisha Nagarsheth;Lili Zhao

  • DPC4 Gene in Various Tumor Types

    Mieke Schutte;Ralph H. Hruban;Lora Hedrick;Kathleen R. Cho

  • Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.

    Hironori Tashiro;Marian S. Blazes;Rong Wu;Kathleen R. Cho

  • Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology

    Wui Jin Koh;Nadeem R. Abu-Rustum;Sarah Bean;Kristin Bradley

  • Frequency of homozygous deletion at p16/CDKN2 in primary human tumours

    P. Cairns;T. J. Polascik;Y. Eby;K. Tokino

  • Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer.

    Colleen D. Hough;Cheryl A. Sherman-Baust;Ellen S. Pizer;F. J. Montz

  • Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage

    Theodore D. Kessis;Robert J. Slebos;William G. Nelson;Michael B. Kastan

  • A Transforming Growth Factor β Receptor Type II Gene Mutation Common in Colon and Gastric but Rare in Endometrial Cancers with Microsatellite Instability

    Lois L. Myeroff;Ramon Parsons;Seong Jin Kim;Lora Hedrick

  • Uterine Neoplasms, Version 1.2018: Clinical practice guidelines in oncology

    Wui Jin Koh;Nadeem R. Abu-Rustum;Sarah Bean;Kristin Bradley

  • Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells

    Cheryl A. Sherman-Baust;Ashani T. Weeraratna;Leticia B.A. Rangel;Ellen S. Pizer

  • Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

    Donald R. Schwartz;Sharon L R Kardia;Kerby A. Shedden;Rork Kuick

  • p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis

    Hironori Tashiro;Christina Isacson;Ross Levine;Robert J. Kurman

  • p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.

    Robbert J. C. Slebos;Mann H. Lee;Beverly S. Plunkett;Theodore D. Kessis

  • ENGINEERING AN INTRACELLULAR PATHWAY FOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II PRESENTATION OF ANTIGENS

    Tzyy-Choou Wu;F. G. Guarnieri;K. F. Staveley-O'carroll;R. P. Viscidi

  • Activation of AXIN2 Expression by β-Catenin-T Cell Factor A FEEDBACK REPRESSOR PATHWAY REGULATING Wnt SIGNALING

    Janet Y. Leung;Frank T. Kolligs;Rong Wu;Yali Zhai

  • Myeloid derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2

    Tracy X. Cui;Ilona Kryczek;Lili Zhao;Ende Zhao

  • Tight Junction Proteins Claudin-3 and Claudin-4 Are Frequently Overexpressed in Ovarian Cancer but Not in Ovarian Cystadenomas

    Leticia B A Rangel;Rachana Agarwal;Theresa D'Souza;Ellen S. Pizer

  • FGF-20 and DKK1 are transcriptional targets of β-catenin and FGF-20 is implicated in cancer and development

    Mario N Chamorro;Mario N Chamorro;Donald R Schwartz;Alin Vonica;Ali H Brivanlou

Frequent Co-Authors

Eric R. Fearon
Eric R. Fearon University of Michigan–Ann Arbor
Rork Kuick
Rork Kuick University of Michigan–Ann Arbor
Bert Vogelstein
Bert Vogelstein Johns Hopkins University
Thomas J. Giordano
Thomas J. Giordano University of Michigan–Ann Arbor
Nadeem R. Abu-Rustum
Nadeem R. Abu-Rustum Memorial Sloan Kettering Cancer Center
Jonathan I. Epstein
Jonathan I. Epstein Johns Hopkins University
Patricia J. Eifel
Patricia J. Eifel The University of Texas MD Anderson Cancer Center
Brigitte M. Ronnett
Brigitte M. Ronnett Johns Hopkins University
David E. Cohn
David E. Cohn The Ohio State University
Sharon L.R. Kardia
Sharon L.R. Kardia University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medical careers in the USA offer diverse pathways, many of which can be accessed or advanced through online study. Whether you’re interested in nursing, healthcare management, or specialized roles, there are flexible online options to help you achieve your goals.

For those aiming to fast-track their professional journey, you may want to explore the shortest dnp program for advanced nursing practice. If you’re looking to enter the workforce quickly, consider what is the fastest way to become an lpn and start gaining valuable clinical experience sooner.

For nurses with an interest in mental health, psych nurse practitioner programs can provide specialized, in-demand training online. Alternatively, if you’re interested in the administrative side of healthcare, you may benefit from an affordable healthcare administration degree online, which prepares graduates for management roles in a rapidly growing field.

Each of these online pathways offers varying lengths, costs, and career outcomes. Exploring your options carefully can help you choose a program that meets both your professional ambitions and your lifestyle needs.

Best Scientists Citing Kathleen R. Cho

Trending Scientists